Adenosine-enhanced ischemic preconditioning decreases infarct in the regional ischemic sheep heart

Annals of Thoracic Surgery

Volumn 66, Issue 2, 1998, Pages 382-387

  Uematsu, Masahisa ^a   Gaudette, Glenn R ^a   Laurikka, Jari O ^a   Levitsky, Sidney ^a   McCully, James D ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; HEPARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ADENOSINE; ANIMALS; BLOOD PRESSURE; HEART RATE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; SHEEP;

EID: 0031707454     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)00501-3     Document Type: Article

References (20)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia a delay of lethal cell injury in ischemic myocardium . Circulation. 74:1986;1124-1136.
2. Lawson C.S., Downy J.M. Preconditioning state of the art myocardial protection . Cardiovasc Res. 27:1993;542-550.
3. Lasley R.D., Anderson G.M., Mentzer R.M. Ischemic preconditioning and hypoxia enhance postischemic recovery of function in the rat heart. Cardiovasc Res. 27:1993;565-570.
4. Asimakis G.K., Lick S.D., Conti V.R. Transient ischemia cannot precondition the rabbit heart against postischemic contractile dysfunction. Ann Thorac Surg. 62:1996;543-549.
5. McCully JD, Ueumatsu M, Levitsky S. Adenosine enhanced ischemic preconditioning provides enhanced post-ischemic recovery and limitation of infarct size in the rabbit heart. J Thorac Cardiovasc Surg (in press).
6. Qiu Y., Hearse D.J. Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused versus blood-perfused hearts. J Thorac Cardiovasc Surg. 103:1992;960-968.
7. Sandhu R., Diaz R.J., Wilson G.J. Comparison of ischemic preconditioning in blood perfusion and buffer perfused isolated heart model. Cardiovasc Res. 27:1993;602-607.
8. Flameng W.J. Role of myocardial protection for coronary artery bypass grafting on the beating heart. Ann Thorac Surg. 63:1997;S18-S22.
9. Vivaldi M.T., Kloner R.A., Schoen F.J. Triphenyltetrazolium staining of irreversible ischemic injury following coronary artery occlusion in rats. Am J Pathol. 121:1985;522-530.
10. Jenkins D.P., Pugsley W.B., Yellon D.M. Ischaemic preconditioning in a model of global ischaemia infarct size limitation, but no reduction of stunning . J Mol Cell Cardiol. 27:1995;1623-1632.
11. Bukhari E.A., Krukenkamp I.B., Burns P.G., et al. Does aprotinin increase the myocardial damage in the setting of ischemia and preconditioning? Ann Thorac Surg. 60:1995;307-310.
12. Van Winkle D.M., Thornton J., Downey J.M. Cardioprotection from ischemic preconditioning is lost following prolonged reperfusion in the rabbit. Coron Artery Dis. 2:1991;613-619.
13. Hecker J.F. The sheep as an experimental animal. 1983;14-93 Academic Press, Orlando, FL.
14. Birnbaum Y., Hale S.L., Kloner R.A. Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyl tetrazolium chloride staining. J Mol Cell Cardiol. 29:1997;657-666.
15. Glower D., Schaper J., Kabas J., et al. Relation between reversal of diastolic creep and recovery of systolic function after ischemic myocardial injury in conscious dogs. Circ Res. 60:1987;850-860.
16. Bolli R. Mechanism of myocardial "stunning." Circulation. 82:1990;723-738.
17. Itoya M., Miura T., Sakamoto J., et al. Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning. J Cardiovasc Pharmacol. 24:1994;846-852.
18. Mizumura T., Auchampach J.A., Linden J., et al. PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Circ Res. 79:1996;415-423.
19. Cohen M.V., Thornton J.D., Thornton C.S., et al. Intravenous co-infusion of adenosine and norepinephrine preconditions the heart without adverse effects. J Thorac Cardiovasc Surg. 114:1997;236-242.
20. Mubagwa K., Mullane K., Flameng W. Role of adenosine in the heart and circulation. Cardiovasc Res. 32:1996;797-813.